Mirae Asset Global Investments
ANAB icon

Mirae Asset Global Investments’s AnaptysBio ANAB Stock Holding History

Mirae Asset Global Investments’s Portfolio ANAB Stock Details ANAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$87.8K Sell
1,301
-143
-10% -$8.67K ﹤0.01% 1260
2026
Q1 		$53.4K Buy
1,444
+99
+7% +$5.33K ﹤0.01% 1283
2025
Q4 		$65.2K Buy
1,345
+263
+24% +$10.3K ﹤0.01% 1342
2025
Q3 		$33.1K Sell
1,082
-53
-5% -$1.22K ﹤0.01% 1413
2025
Q2 		$25.2K Buy
1,135
+109
+11% +$2.28K ﹤0.01% 1364
2025
Q1 		$19.4K Buy
1,026
+12
+1% +$200 ﹤0.01% 1389
2024
Q4 		$13.2K Sell
1,014
-78
-7% -$1.89K ﹤0.01% 1482
2024
Q3 		$34.8K Buy
1,092
+276
+34% +$9.43K ﹤0.01% 1362
2024
Q2 		$20.2K Sell
816
-11,315
-93% -$263K ﹤0.01% 1376
2024
Q1 		$265K Buy
+12,131
New +$287K ﹤0.01% 2158
2023
Q4 		– Sell
-11,231
Closed -$202K – 2528
2023
Q3 		$202K Sell
11,231
-1,141
-9% -$21.8K ﹤0.01% 2293
2023
Q2 		$251K Buy
12,372
+137
+1% +$2.78K ﹤0.01% 2258
2023
Q1 		$266K Buy
+12,235
New +$297K ﹤0.01% 2217

Other funds holding ANAB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
BFG
Bleakley Financial Group Fairfield, New Jersey $7.85B AUM 31.48% 1-Year Est. Return
TE
Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return

Mirae Asset Global Investments's ANAB Position: Q2 2026 in Review

Mirae Asset Global Investments reduced its AnaptysBio (ANAB) stake by 9.9% in Q2 2026, selling an estimated $8.67K and leaving 1,301 shares worth $87.8K. The position accounts for ﹤0.01% of the portfolio, ranked #1260.

Mirae Asset Global Investments first reported a position in ANAB in Q1 2023 and has held it in 13 quarters since. The position peaked at $266K in Q1 2023. 61 funds tracked by Wall St. Rank hold ANAB as of Q2 2026.

  • Mirae Asset Global Investments held 1,301 shares of AnaptysBio worth $87.8K as of Q2 2026.
  • Mirae Asset Global Investments sold 143 AnaptysBio shares in Q2 2026, an estimated $8.67K.
  • AnaptysBio made up ﹤0.01% of Mirae Asset Global Investments's portfolio in Q2 2026, its #1260 holding.
  • Mirae Asset Global Investments first reported a position in AnaptysBio in Q1 2023 and has held it in 13 quarters since.
  • Mirae Asset Global Investments's AnaptysBio position peaked at $266K in Q1 2023.
  • 61 funds tracked by Wall St. Rank held AnaptysBio as of Q2 2026.

Based on Mirae Asset Global Investments's 13F filing for Q2 2026, filed 22 Jul 2026.